Inception Return
(11/28/1997)
|
8.08 %
|
|
YTD Return
|
11.28 %
|
|
NAVPS
(7/8/2026)
|
$63.33
|
|
Change
|
($0.80) / -1.25 %
|
|
|
Growth of $10,000
(As of May 31, 2026)
|
|
MER
|
2.44 %
|
|
Assets ($mil)
|
$452.94
|
|
Rank (1Yr)
|
79/283
|
|
Std Dev (3Yr)
|
15.04 %
|
|
Volatility Ranking (3Yr)
|
9/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
No Load
|
|
Max Front End
|
-
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
The fundamental investment objective is to seek to achieve long-term capital growth by investing primarily in equity securities of small or medium-sized issuers in the United States. The fundamental investment objective may only be changed with the approval of a majority of unitholders, given at a meeting called for that purpose.
|
Fund Manager
TD Asset Management Inc.
Portfolio Manager
TD Asset Management Inc.
Sub-Advisor
Alexander Roik, T. Rowe Price Associates, Inc.
|
|
Asset Allocation
(As of May 31, 2026)
|
Sector Allocation
(As of May 31, 2026)
|
Geographic Allocation
(As of May 31, 2026)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Liberty Live Holdings Inc | US Equity | Other | United States | 2.55% |
| Lattice Semiconductor Corp | US Equity | Technology | United States | 2.28% |
| VSE Corp | US Equity | Industrial Goods | United States | 1.77% |
| Dyne Therapeutics Inc | US Equity | Healthcare | United States | 1.56% |
| Immunome Inc | US Equity | Healthcare | United States | 1.55% |
| Brightspring Health Services Inc | US Equity | Healthcare | United States | 1.51% |
| SiTime Corp | US Equity | Technology | United States | 1.34% |
| Loar Holdings Inc | US Equity | Industrial Goods | United States | 1.25% |
| ESAB Corp | US Equity | Industrial Goods | United States | 1.20% |
| Cytokinetics Inc | US Equity | Healthcare | United States | 1.14% |
Performance Data
(As of May 31, 2026)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
3.16
|
3.56
|
8.59
|
11.28
|
23.80
|
14.89
|
5.90
|
10.19
|
|
Benchmark
|
5.62
|
8.10
|
14.60
|
14.88
|
31.10
|
20.20
|
10.94
|
11.75
|
|
Quartile Ranking
|
2
|
2
|
2
|
2
|
2
|
1
|
2
|
1
|
|
Calendar Return (%)
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|
Fund
|
1.69
|
19.12
|
12.78
|
-19.46
|
13.64
|
20.01
|
25.15
|
3.41
|
5.66
|
12.19
|
|
Benchmark
|
7.19
|
24.39
|
13.76
|
-11.77
|
20.00
|
11.78
|
21.65
|
-2.87
|
8.66
|
14.08
|
|
Quartile Ranking
|
2
|
2
|
2
|
4
|
4
|
1
|
1
|
2
|
4
|
2
|